In yesterday’s Wall Street session, Roivant Sciences Ltd (NASDAQ:ROIV) shares traded at $10.84, up 7.54% from the previous session.
ROIV stock price is now 1.10% away from the 50-day moving average and 2.82% away from the 200-day moving average. The market capitalization of the company currently stands at $8.74B.
With the price target of $17, Wolfe Research recently initiated with Outperform rating for Roivant Sciences Ltd (NASDAQ: ROIV). On January 05, 2024, Piper Sandler recently initiated its ‘Overweight’ rating on the stock quoting a target price of $20, while ‘Deutsche Bank’ rates the stock as ‘Buy’
In other news, Venker Eric, President & COO sold 96,950 shares of the company’s stock on Feb 09 ’24. The stock was sold for $1,058,694 at an average price of $10.92. Upon completion of the transaction, the President & COO now directly owns 532,207 shares in the company, valued at $5.77 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 02 ’24, 10% Owner Ramaswamy Vivek sold 3,000,000 shares of the business’s stock. A total of $33,150,000 was realized by selling the stock at an average price of $11.05. This leaves the insider owning 51,929,426 shares of the company worth $562.91 million. A total of 40.16% of the company’s stock is owned by insiders.
During the past 12 months, Roivant Sciences Ltd has had a low of $6.92 and a high of $13.24. As of last week, the company has a debt-to-equity ratio of 0.08, a current ratio of 27.79, and a quick ratio of 27.77. The fifty day moving average price for ROIV is $10.72 and a two-hundred day moving average price translates $10.55 for the stock.
The latest earnings results from Roivant Sciences Ltd (NASDAQ: ROIV) was released for Dec, 2023. According to the Biotechnology Company, earnings per share came in at $6.03, beating analysts’ expectations of -$0.32 by 6.35. This compares to -$0.54 EPS in the same period last year. The net profit margin was 3624.14% and return on equity was 123.54% for ROIV. The company reported revenue of $37.14 million for the quarter, compared to $17.05 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 117.8 percent. For the current quarter, analysts expect ROIV to generate $33.28M in revenue.
